DSIP: Delta Sleep-Inducing Peptide Research

Research on the neuropeptide for sleep, stress, and recovery optimization

Source: https://indexalabs.com/blog/dsip-delta-sleep-inducing-peptide-research Abstract: Delta Sleep-Inducing Peptide (DSIP) is a neuropeptide originally isolated for its sleep-promoting effects. Research has expanded to include stress modulation, pain management, and hormone regulation.

1. Overview

DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) is a nine-amino acid neuropeptide first isolated from rabbit brain in 1977. Named for its ability to induce delta wave (slow-wave) sleep, subsequent research has revealed broader neuromodulatory effects.

2. Mechanisms of Action

2.1 Sleep Architecture DSIP promotes slow-wave (delta) sleep, the most restorative phase of the sleep cycle.

2.2 Stress Response Modulates the HPA axis, potentially reducing stress hormone release.

2.3 Endorphin Release May stimulate endogenous opioid peptide release.

2.4 LH Release Research suggests effects on luteinizing hormone and gonadal function.

3. Research Applications

3.1 Sleep Disorders Research on insomnia, sleep architecture disruption, and jet lag.

3.2 Chronic Stress Studies on stress-related conditions and adrenal function.

3.3 Pain Research Investigation of analgesic properties through endorphin modulation.

3.4 Withdrawal Studies Research on substance withdrawal and recovery support.

4. Research Protocols

4.1 Available Sizes DSIP is available in 10mg vials.

4.2 Timing Research typically involves evening administration aligned with natural sleep onset.

4.3 Blood-Brain Barrier DSIP crosses the blood-brain barrier, allowing peripheral administration.